How Glucagon Impacts Type 1 Diabetes and Vice Versa

Diabetesincontrol.com

Klicken Sie hier, um Diabetesincontrol.com zu abonnieren

Kategorien: Gesundheit | Wohlfahrt Gesundheit Bildung Alter: 14 - 18 Jahr 19 - 30 Jahr 31 - 64 Jahre

Laden...

3 jahre vor

Html
Text

Plus: semaglutide for weight loss with or without diabetes; more

Saturday, Sept. 4, 2021 : Issue #1164

TOP STORIES - Diabetes News & Research

How Glucagon Impacts Type 1 Diabetes and Vice Versa
By Sheri Colberg, PhD
Don't Forget our Patients with Type 1 Diabetes
Good Hygiene Can Prevent Infections in Patients with Diabetes
Children that Develop T2D Have Worse Clinical Outcomes and Fewer Treatment Options
Semaglutide 2.4 mg Once Weekly for Weight Management in Patients With Or Without T2D
New Innovative Extended Wear Infusion Set

Letter from the Editor
I have recently been cycling with some insulin pump patients, and they often complain about their problems with fluctuating glucose levels, before, during, and after they ride. We have tried many fixes and changes to see if we can control the fluctuations, but there does not seem to be a consistent solution. When I discussed this with Dr. Sheri Colberg, PhD, she decided to prepare an in-depth article on what the causes and solutions might be.
If you click on her feature on Glucagon and Type 1 Diabetes, the concepts and ideas she shares make perfect sense, and can be used for most all of your active patients.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief

TOP STORIES - Diabetes News and Research

How Glucagon Impacts Type 1 Diabetes and Vice Versa
By Sheri Colberg, PhD
Glucagon is such an important hormone when it comes to blood glucose management in everyone—and it both impacts and is impacted by type 1 diabetes (T1D). A recent mini-review in Physiological Reports focused on altered glucagon responses brought up some interesting points that are worth discussing further.

Don't Forget our Patients with Type 1 Diabetes
Cardiovascular and renal disease burdens also occur in type 1 diabetes.

Good Hygiene Can Prevent Infections in Patients with Diabetes
Maintaining proper skincare can help in preventing infections when using diabetes devices.

Children that Develop T2D Have Worse Clinical Outcomes and Fewer Treatment Options
When metformin therapy fails in youth, alternatives are limited to human insulin and liraglutide.

Semaglutide 2.4 mg Once Weekly for Weight Management in Patients With Or Without T2D
Patients who have obesity but don't have diabetes may now reap the benefits of using a GLP-1 receptor agonist.

New Innovative Extended Wear Infusion Set
Medtronic recently announced the launch of its new extended infusion set.

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week's newsletters:

Dalia Elabed, PharmD Candidate 2022, University of South Florida Taneja College of Pharmacy

Jerrine Fletcher, Doctor of Pharmacy Candidate, Florida A&M University College of Pharmacy and Pharmaceutical Sciences

Macrina Ghali, PharmD Candidate 2021, Florida A&M University, College of Pharmacy and Pharmaceutical Sciences

Kornelia Ilias, Creighton University | School of Pharmacy and Health Professions Doctor of Pharmacy Candidate Class of 2022

Laura Martínez López, PharmD. Candidate 2021, Lake Erie College of Osteopathic Medicine, College of Pharmacy

Brenda Oppong, PharmD Candidate, LECOM School of Pharmacy

Joan Prifti, PharmD. Candidate, LECOM College of Pharmacy

About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.

Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
www.diabetesincontrol.com

©2021 HIPER, LLC. All rights reserved.
This email was sent by eHealthcare Solutions on behalf of: Diabetes In Control
2093 Philadelphia Pike #8370
Claymont, DE, 19703, United States
DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe

Teilen auf

Laden...

Weitere Newsletter von Diabetesincontrol.com

Laden...

Andere Kategorien anzeigen

Gesundheit | Wohlfahrt Gesundheit Bildung

How Glucagon Impacts Type 1 Diabetes and Vice Versa

Saturday, Sept. 4, 2021 : Issue #1164

TOP STORIES - Diabetes News & Research

TOP STORIES - Diabetes News and Research

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week's newsletters:

Teilen auf

Weitere Newsletter von Diabetesincontrol.com

Verwandte Newsletter

Andere Kategorien anzeigen